Yousef Al-Kofahi
General Electric
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yousef Al-Kofahi.
JCI insight | 2017
Eliot T. McKinley; Yunxia Sui; Yousef Al-Kofahi; Bryan A. Millis; Matthew J. Tyska; Joseph T. Roland; Alberto Santamaria-Pang; Christina L. Ohland; Christian Jobin; Jeffrey L. Franklin; Ken S. Lau; Michael J. Gerdes; Robert J. Coffey
Intestinal tuft cells are a rare, poorly understood cell type recently shown to be a critical mediator of type 2 immune response to helminth infection. Here, we present advances in segmentation algorithms and analytical tools for multiplex immunofluorescence (MxIF), a platform that enables iterative staining of over 60 antibodies on a single tissue section. These refinements have enabled a comprehensive analysis of tuft cell number, distribution, and protein expression profiles as a function of anatomical location and physiological perturbations. Based solely on DCLK1 immunoreactivity, tuft cell numbers were similar throughout the mouse small intestine and colon. However, multiple subsets of tuft cells were uncovered when protein coexpression signatures were examined, including two new intestinal tuft cell markers, Hopx and EGFR phosphotyrosine 1068. Furthermore, we identified dynamic changes in tuft cell number, composition, and protein expression associated with fasting and refeeding and after introduction of microbiota to germ-free mice. These studies provide a foundational framework for future studies of intestinal tuft cell regulation and demonstrate the utility of our improved MxIF computational methods and workflow for understanding cellular heterogeneity in complex tissues in normal and disease states.
Cancer Research | 2016
Mark T. Uhlik; Jiangang Liu; Beverly L. Falcon; Seema Iyer; Julie Stewart; Hilal Celikkaya; Marguerita O'Mahony; Christopher Sevinsky; Christina Lowes; Larry E. Douglass; Cynthia Jeffries; Diane M. Bodenmiller; Sudhakar Chintharlapalli; Anthony S. Fischl; Damien Gerald; Qi Xue; Jee-yun Lee; Alberto Santamaria-Pang; Yousef Al-Kofahi; Yunxia Sui; Keyur Desai; Thompson N. Doman; Amit Aggarwal; Julia H. Carter; Bronislaw Pytowski; Shou-Ching Jaminet; Fiona Ginty; Aejaz Nasir; Janice A. Nagy; Harold F. Dvorak
Treatment of metastatic gastric cancer typically involves chemotherapy and monoclonal antibodies targeting HER2 (ERBB2) and VEGFR2 (KDR). However, reliable methods to identify patients who would benefit most from a combination of treatment modalities targeting the tumor stroma, including new immunotherapy approaches, are still lacking. Therefore, we integrated a mouse model of stromal activation and gastric cancer genomic information to identify gene expression signatures that may inform treatment strategies. We generated a mouse model in which VEGF-A is expressed via adenovirus, enabling a stromal response marked by immune infiltration and angiogenesis at the injection site, and identified distinct stromal gene expression signatures. With these data, we designed multiplexed IHC assays that were applied to human primary gastric tumors and classified each tumor to a dominant stromal phenotype representative of the vascular and immune diversity found in gastric cancer. We also refined the stromal gene signatures and explored their relation to the dominant patient phenotypes identified by recent large-scale studies of gastric cancer genomics (The Cancer Genome Atlas and Asian Cancer Research Group), revealing four distinct stromal phenotypes. Collectively, these findings suggest that a genomics-based systems approach focused on the tumor stroma can be used to discover putative predictive biomarkers of treatment response, especially to antiangiogenesis agents and immunotherapy, thus offering an opportunity to improve patient stratification. Cancer Res; 76(9); 2573-86. ©2016 AACR.
Journal of Pathology Informatics | 2016
Daniel M. Spagnolo; Rekha Gyanchandani; Yousef Al-Kofahi; Timothy R. Lezon; Albert Gough; Daniel Eugene Meyer; Fiona Ginty; Brion Daryl Sarachan; Jeffrey L. Fine; Adrian V. Lee; D. Lansing Taylor; S. Chakra Chennubhotla
Background: Measures of spatial intratumor heterogeneity are potentially important diagnostic biomarkers for cancer progression, proliferation, and response to therapy. Spatial relationships among cells including cancer and stromal cells in the tumor microenvironment (TME) are key contributors to heterogeneity. Methods: We demonstrate how to quantify spatial heterogeneity from immunofluorescence pathology samples, using a set of 3 basic breast cancer biomarkers as a test case. We learn a set of dominant biomarker intensity patterns and map the spatial distribution of the biomarker patterns with a network. We then describe the pairwise association statistics for each pattern within the network using pointwise mutual information (PMI) and visually represent heterogeneity with a two-dimensional map. Results: We found a salient set of 8 biomarker patterns to describe cellular phenotypes from a tissue microarray cohort containing 4 different breast cancer subtypes. After computing PMI for each pair of biomarker patterns in each patient and tumor replicate, we visualize the interactions that contribute to the resulting association statistics. Then, we demonstrate the potential for using PMI as a diagnostic biomarker, by comparing PMI maps and heterogeneity scores from patients across the 4 different cancer subtypes. Estrogen receptor positive invasive lobular carcinoma patient, AL13-6, exhibited the highest heterogeneity score among those tested, while estrogen receptor negative invasive ductal carcinoma patient, AL13-14, exhibited the lowest heterogeneity score. Conclusions: This paper presents an approach for describing intratumor heterogeneity, in a quantitative fashion (via PMI), which departs from the purely qualitative approaches currently used in the clinic. PMI is generalizable to highly multiplexed/hyperplexed immunofluorescence images, as well as spatial data from complementary in situ methods including FISSEQ and CyTOF, sampling many different components within the TME. We hypothesize that PMI will uncover key spatial interactions in the TME that contribute to disease proliferation and progression.
Cancer Research | 2017
Daniel M. Spagnolo; Yousef Al-Kofahi; Peihong Zhu; Timothy R. Lezon; Albert Gough; Adrian V. Lee; Fiona Ginty; Brion Daryl Sarachan; D. Lansing Taylor; S. Chakra Chennubhotla
We introduce THRIVE (Tumor Heterogeneity Research Interactive Visualization Environment), an open-source tool developed to assist cancer researchers in interactive hypothesis testing. The focus of this tool is to quantify spatial intratumoral heterogeneity (ITH), and the interactions between different cell phenotypes and noncellular constituents. Specifically, we foresee applications in phenotyping cells within tumor microenvironments, recognizing tumor boundaries, identifying degrees of immune infiltration and epithelial/stromal separation, and identification of heterotypic signaling networks underlying microdomains. The THRIVE platform provides an integrated workflow for analyzing whole-slide immunofluorescence images and tissue microarrays, including algorithms for segmentation, quantification, and heterogeneity analysis. THRIVE promotes flexible deployment, a maintainable code base using open-source libraries, and an extensible framework for customizing algorithms with ease. THRIVE was designed with highly multiplexed immunofluorescence images in mind, and, by providing a platform to efficiently analyze high-dimensional immunofluorescence signals, we hope to advance these data toward mainstream adoption in cancer research. Cancer Res; 77(21); e71-74. ©2017 AACR.
Proceedings of SPIE | 2011
Peter O. Ajemba; Yousef Al-Kofahi; Richard Scott; Michael J. Donovan; Gerardo Fernandez
Automatic segmentation of cellular structures is an essential step in image cytology and histology. Despite substantial progress, better automation and improvements in accuracy and adaptability to novel applications are needed. In applications utilizing multi-channel immuno-fluorescence images, challenges include misclassification of epithelial and stromal nuclei, irregular nuclei and cytoplasm boundaries, and over and under-segmentation of clustered nuclei. Variations in image acquisition conditions and artifacts from nuclei and cytoplasm images often confound existing algorithms in practice. In this paper, we present a robust and accurate algorithm for jointly segmenting cell nuclei and cytoplasm using a combination of ideas to reduce the aforementioned problems. First, an adaptive process that includes top-hat filtering, Eigenvalues-of-Hessian blob detection and distance transforms is used to estimate the inverse illumination field and correct for intensity non-uniformity in the nuclei channel. Next, a minimum-error-thresholding based binarization process and seed-detection combining Laplacian-of-Gaussian filtering constrained by a distance-map-based scale selection is used to identify candidate seeds for nuclei segmentation. The initial segmentation using a local maximum clustering algorithm is refined using a minimum-error-thresholding technique. Final refinements include an artifact removal process specifically targeted at lumens and other problematic structures and a systemic decision process to reclassify nuclei objects near the cytoplasm boundary as epithelial or stromal. Segmentation results were evaluated using 48 realistic phantom images with known ground-truth. The overall segmentation accuracy exceeds 94%. The algorithm was further tested on 981 images of actual prostate cancer tissue. The artifact removal process worked in 90% of cases. The algorithm has now been deployed in a high-volume histology analysis application.
international symposium on biomedical imaging | 2016
Yousef Al-Kofahi; Christopher Sevinsky; Alberto Santamaria-Pang; Fiona Ginty; Anup Sood; Qing Li
Angiogenesis is the development of new vasculature from existing vasculature. The developmental biology and pathology of angiogenesis are major focuses of biomedical research. While many segmentation algorithms have been implemented for blood vessel analysis, they are limited by maturation dependent variation in blood vessel protein expression, expression by other cell types and discontinuous vessel staining due to tissue sectioning. We describe a method that combines image data from multiple blood vessel-expressed proteins to dynamically estimate optimal correlation metrics to drive improved vessel segmentation. A single marker approach resulted in overestimation of vessel number, whereas the multi-channel algorithm agreed closely with manual counts generated by two independent observers. Our results suggest that this new approach improves the vessel segmentation, which will be useful in the study of angiogenesis in health and disease.
Proceedings of SPIE | 2013
Yousef Al-Kofahi; Dirk R. Padfield; Antti E. Seppo
Fluorescence in situ hybridization (FISH) dot counting is the process of enumerating chromosomal abnormalities in interphase cell nuclei. This process is widely used in many areas of biomedical research and diagnosis. We present a generic and fully automatic algorithm for cell-level counting of FISH dots in 2-D fluorescent images. Our proposed algorithm starts by segmenting cell nuclei in DAPI stained images using a 2-D wavelet based segmentation algorithm. Nuclei segmentation is followed by FISH dot detection and counting, which consists of three main steps. First, image pre-processing where median and top-hat filters are used to clean image noise, subtract background and enhance the contrast of the FISH dots. Second, FISH dot detection using a multi-level h-minima transform approach that accounts for the varying image contrast. Third, FISH dot counting where clustered FISH dots are separated using a local maxima detection-based method followed by FISH dot size filtering based on constraints to account for large connected components of tightly-clustered dots. To quantitatively assess the performance of our proposed FISH dot counting algorithm, automatic counting results were compared to manual counts of 880 cells selected from 19 invasive ductal breast carcinoma samples exhibiting varying degrees of Human Epidermal Growth Factor Receptor 2 (HER2) expression. Cell-level dot counting accuracy was assessed using two metrics: cell classification agreement and dot-counting match. Our automatic results gave an overall cell-by-cell classification agreement of 88% and an overall accuracy of 81%.
Archive | 2014
Yousef Al-Kofahi; Brion Daryl Sarachan
Archive | 2013
Antti E. Seppo; Yousef Al-Kofahi; Dirk R. Padfield
international symposium on biomedical imaging | 2018
Yousef Al-Kofahi; Ginty Fiona